See more : Senetas Corporation Limited (SEN.AX) Income Statement Analysis – Financial Results
Complete financial analysis of AlerisLife Inc. (ALR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of AlerisLife Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- bBreak Systems Company, Limited (3986.T) Income Statement Analysis – Financial Results
- Intevac, Inc. (IVAC) Income Statement Analysis – Financial Results
- Golden Sun Education Group Limited (GSUN) Income Statement Analysis – Financial Results
- Mushrooms Inc (MSRM) Income Statement Analysis – Financial Results
- SSP Group plc (SSPG.L) Income Statement Analysis – Financial Results
AlerisLife Inc. (ALR)
About AlerisLife Inc.
AlerisLife Inc. operates and manages senior living communities in the United States. It operates through two segments, Residential and Lifestyle Services. Its senior living communities comprise independent living communities, assisted living communities, memory care, continuing care retirement communities (CCRCs), skilled nursing facilities (SNFs), and an active adult community. The company offers nursing and healthcare services; and outpatient rehabilitation clinics and fitness services. As of December 31, 2021, it owned and operated or managed, 141 senior living communities located in 28 states with 20,105 living units, including 10,423 independent living apartments, 9,636 assisted living suites, which includes 1,872 of Bridge to Rediscovery memory care units, and one continuing CCRC, with 106 living units, including 46 SNF. The company was formerly known as Five Star Senior Living Inc. and changed its name to AlerisLife Inc. in January 2022. AlerisLife Inc. was incorporated in 2001 and is headquartered in Newton, Massachusetts.
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 934.59M | 1.16B | 1.42B | 1.39B | 1.40B | 1.38B | 1.37B | 1.33B | 1.30B | 1.35B | 1.28B | 1.24B | 1.19B | 1.10B | 972.92M | 827.34M | 757.53M | 628.01M | 576.22M | 522.51M | 229.24M |
| Cost of Revenue | 851.46M | 1.05B | 1.19B | 1.15B | 1.10B | 1.08B | 1.07B | 1.05B | 1.00B | 1.04B | 449.95M | 954.29M | 934.93M | 863.39M | 763.10M | 263.90M | 183.89M | 159.89M | 151.01M | 182.54M | 72.97M |
| Gross Profit | 83.13M | 115.79M | 229.87M | 245.05M | 291.74M | 297.77M | 292.11M | 282.99M | 294.80M | 309.16M | 831.82M | 286.44M | 257.63M | 240.81M | 209.82M | 563.44M | 573.64M | 468.11M | 425.20M | 339.97M | 156.27M |
| Gross Profit Ratio | 8.90% | 9.95% | 16.24% | 17.62% | 20.90% | 21.61% | 21.39% | 21.31% | 22.73% | 22.89% | 64.90% | 23.09% | 21.60% | 21.81% | 21.57% | 68.10% | 75.72% | 74.54% | 73.79% | 65.06% | 68.17% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 85.72M | 92.29M | 229.37M | 287.34M | 281.74M | 275.18M | 269.83M | 269.74M | 257.33M | 263.24M | 789.34M | 243.87M | 231.46M | 207.54M | 43.37M | 33.83M | 27.78M | 20.05M | 0.00 | 0.00 | 15.42M |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 129.19M | 504.23M | 615.46M | 441.07M | 0.00 | 0.00 | 139.10M |
| SG&A | 85.72M | 92.29M | 229.37M | 287.34M | 281.74M | 275.18M | 269.83M | 269.74M | 257.33M | 263.24M | 789.34M | 243.87M | 231.46M | 207.54M | 172.56M | 538.06M | 643.24M | 461.12M | 428.02M | 345.16M | 154.51M |
| Other Expenses | 4.08M | 7.56M | 16.64M | 35.94M | 38.19M | 38.05M | 33.82M | 31.83M | 27.02M | 25.06M | 21.13M | 16.80M | 16.38M | 8.79M | 13.60M | 139.86M | 7.11M | 3.67M | 3.59M | 1.89M | 1.27M |
| Operating Expenses | 89.80M | 99.85M | 246.01M | 323.28M | 319.94M | 313.24M | 303.65M | 301.58M | 284.35M | 288.30M | 810.47M | 260.67M | 247.84M | 216.33M | 186.16M | 677.92M | 650.35M | 464.79M | 431.61M | 347.05M | 155.78M |
| Cost & Expenses | 941.26M | 1.15B | 1.43B | 1.47B | 1.42B | 1.39B | 1.38B | 1.35B | 1.29B | 1.33B | 1.26B | 1.21B | 1.18B | 1.08B | 949.26M | 941.82M | 834.24M | 624.68M | 582.62M | 529.59M | 228.75M |
| Interest Income | 358.00K | 757.00K | 1.36M | 818.00K | 765.00K | 984.00K | 982.00K | 867.00K | 781.00K | 881.00K | 1.30M | 1.82M | 2.99M | 5.92M | 6.15M | 6.81M | 1.54M | 1.67M | 229.00K | 297.00K | 43.00K |
| Interest Expense | 1.68M | 1.63M | 2.62M | 3.02M | 4.31M | 4.91M | 4.93M | 5.13M | 5.23M | 6.27M | 3.92M | 3.05M | 4.37M | 6.34M | 6.80M | 4.37M | 3.74M | 880.00K | 1.16M | 198.00K | 198.00K |
| Depreciation & Amortization | 11.87M | 11.75M | 16.64M | 35.94M | 38.19M | 38.05M | 33.67M | 33.47M | 28.11M | 25.06M | 21.13M | 16.80M | 16.38M | 14.72M | 13.60M | 9.95M | 7.11M | 3.67M | 3.59M | 1.89M | 1.32M |
| EBITDA | 5.57M | 27.70M | 1.87M | -34.88M | 17.06M | 23.50M | -3.82M | 9.58M | 32.91M | 61.92M | 38.69M | 44.79M | 61.27M | 17.95M | 45.13M | -102.35M | -73.30M | 7.96M | -3.19M | -11.09M | 1.85M |
| EBITDA Ratio | 0.60% | 2.38% | 0.13% | -2.51% | 1.22% | 1.71% | -0.28% | 0.72% | 2.54% | 4.58% | 3.02% | 3.61% | 5.14% | 1.63% | 4.64% | -12.37% | -9.68% | 1.27% | -0.55% | -2.12% | 0.81% |
| Operating Income | -6.31M | 15.94M | -14.77M | -71.56M | -23.05M | -15.97M | -37.02M | -19.18M | 10.26M | 20.86M | 21.35M | 25.77M | 9.80M | 18.55M | 23.66M | -114.48M | -76.71M | 3.32M | -6.40M | -10.03M | 484.00K |
| Operating Income Ratio | -0.67% | 1.37% | -1.04% | -5.15% | -1.65% | -1.16% | -2.71% | -1.44% | 0.79% | 1.54% | 1.67% | 2.08% | 0.82% | 1.68% | 2.43% | -13.84% | -10.13% | 0.53% | -1.11% | -1.92% | 0.21% |
| Total Other Income/Expenses | -23.21M | -22.87M | -5.74M | -2.79M | -2.99M | -3.82M | -3.09M | -3.87M | -5.23M | -1.79M | -3.63M | 441.00K | 31.66M | -16.74M | 3.84M | 2.44M | -4.53M | 786.00K | 0.00 | -348.00K | 43.00K |
| Income Before Tax | -29.51M | -6.93M | -20.51M | -74.35M | -26.05M | -19.79M | -40.12M | -23.05M | 5.03M | 19.07M | 17.72M | 26.21M | 41.45M | 1.82M | 27.51M | -112.04M | -81.25M | 4.11M | 0.00 | -10.38M | 527.00K |
| Income Before Tax Ratio | -3.16% | -0.60% | -1.45% | -5.35% | -1.87% | -1.44% | -2.94% | -1.74% | 0.39% | 1.41% | 1.38% | 2.11% | 3.48% | 0.16% | 2.83% | -13.54% | -10.73% | 0.65% | 0.00% | -1.99% | 0.23% |
| Income Tax Expense | 234.00K | 663.00K | 56.00K | 247.00K | -4.54M | 2.35M | 662.00K | 56.39M | 1.92M | 5.64M | -50.55M | 1.45M | 2.20M | 1.39M | 1.41M | 4.63M | 2.91M | 120.00K | 1.16M | -150.00K | 2.80M |
| Net Income | -29.75M | -7.59M | -20.57M | -74.08M | -20.90M | -21.81M | -43.08M | -85.41M | -2.34M | 24.95M | 64.20M | 23.49M | 38.33M | -4.50M | 23.33M | -116.67M | -84.16M | 3.29M | -7.94M | -13.17M | 527.00K |
| Net Income Ratio | -3.18% | -0.65% | -1.45% | -5.33% | -1.50% | -1.58% | -3.16% | -6.43% | -0.18% | 1.85% | 5.01% | 1.89% | 3.21% | -0.41% | 2.40% | -14.10% | -11.11% | 0.52% | -1.38% | -2.52% | 0.23% |
| EPS | -0.94 | -0.24 | -4.11 | -14.91 | -4.25 | -4.47 | -8.90 | -17.78 | -0.48 | 5.20 | 15.23 | 6.57 | 11.42 | -1.41 | 7.36 | -40.78 | -56.56 | 3.78 | -9.36 | -17.44 | 1.20 |
| EPS Diluted | -0.94 | -0.24 | -4.11 | -14.91 | -4.25 | -4.47 | -8.90 | -17.78 | -0.48 | 5.20 | 14.26 | 5.99 | 9.89 | -1.41 | 5.63 | -40.78 | -56.56 | 3.78 | -9.36 | -17.44 | 1.20 |
| Weighted Avg Shares Out | 31.59M | 31.47M | 5.01M | 4.97M | 4.92M | 4.88M | 4.84M | 4.80M | 4.83M | 4.80M | 4.22M | 3.57M | 3.36M | 3.19M | 3.17M | 2.86M | 1.49M | 871.60K | 848.20K | 755.60K | 437.40K |
| Weighted Avg Shares Out (Dil) | 31.59M | 31.47M | 5.01M | 4.97M | 4.92M | 4.88M | 4.84M | 4.80M | 4.93M | 4.80M | 4.50M | 3.92M | 3.88M | 3.19M | 4.14M | 2.86M | 1.49M | 871.60K | 848.20K | 755.60K | 437.40K |
AlerisLife and Five Star Senior Living Awarded Great Place to Work® Certification
NEWTON, Mass.--(BUSINESS WIRE)--AlerisLife Inc. and its senior living operating division, Five Star Senior Living, have been awarded with a Great Place to Work certification.
AlerisLife Announces Closing of Tender Offer
NEWTON, Mass.--(BUSINESS WIRE)--AlerisLife Inc. (Nasdaq: ALR) today announced that ABP Acquisition LLC, or ABP, has successfully completed the previously announced tender offer to acquire all outstanding shares of the common stock of ALR for $1.31 per share in cash. $1.31...
AlerisLife Announces Closing of Tender Offer
NEWTON, Mass.--(BUSINESS WIRE)--AlerisLife Inc. (Nasdaq: ALR) today announced that ABP Acquisition LLC, or ABP, has successfully completed the previously announced tender offer to acquire all outstanding shares of the common stock of ALR for $1.31 per share in cash. $1.31...
Healthcare REITs: Life After The Pandemic
For Healthcare REITs - the physical epicenter of the pandemic - the road to recovery has remained inconsistent across its distinct sub-sectors, with "private-pay" segments now showing notable improvement while "public-pay" segments relapse. Public-pay segments - Hospital and Skilled-Nursing -...
Warm Winter For Global Economy
U.S. equity markets rebounded following their worst week of the year as investors parsed data showing surprising resilience in global economic activity this winter despite stiff interest rate headwinds. Snapping a three-week skid and notching its best week since late...
ALERISLIFE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AlerisLife Inc. - ALR
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of AlerisLife Inc. (NasdaqCM: ALR) to ABP Acquisition LLC. Under the terms...
ALERISLIFE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AlerisLife Inc. - ALR
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of AlerisLife Inc. (NasdaqCM: ALR) to ABP Acquisition LLC. Under the terms...
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AlerisLife Inc. (ALR)
NEW YORK--(BUSINESS WIRE)--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating whether the Board of Directors of AlerisLife Inc. ("AlerisLife" or the "Company") (NASDAQ: ALR) breached their fiduciary duties in connection with the proposed sale of the Company to ABP Acquisition...
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of AlerisLife Inc. (ALR)
NEW YORK--(BUSINESS WIRE)---- $ALR #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating whether the Board of Directors of AlerisLife Inc. ("AlerisLife" or the "Company") (NASDAQ: ALR) breached their fiduciary duties in connection with the proposed sale of the Company to...
ALERISLIFE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of AlerisLife Inc. - ALR
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of AlerisLife Inc. (NasdaqCM: ALR) to ABP Acquisition LLC. Under the terms...
Source: https://incomestatements.info
Category: Stock Reports